Salarius Pharmaceuticals to Participate in BIO International Convention 2022 Back Salarius Pharmaceuticals to Participate in BIO International Convention 2022 Read More
Salarius Pharmaceuticals to Report Fourth Quarter and Full-Year 2021 Financial Results and Highlight Recent Company Progress Back Salarius Pharmaceuticals to Report Fourth Quarter and Full-Year 2021 Financial Results and Highlight Recent Company Progress Read More
Salarius Pharmaceuticals Expands Oncology Pipeline Through Strategic Acquisition of Targeted Protein Degradation Portfolio from DeuteRx, LLC Back Salarius Pharmaceuticals Expands Oncology Pipeline Through Strategic Acquisition of Targeted Protein Degradation Portfolio from DeuteRx, LLC Contact Tiberend Strategic Advisors, Inc. Johanna Bennett jbennett@tiberend.com Download PDF